Starting from our recent observation that KCTD15 is upregulated in both B-ALL9 and AML cell lines10 and patient-derived samples, we here found an intriguing link between the upregulation of the protein and the activation of the NF-κB pathway that was observed in different contexts and conditions. Here, KCTD15 is linked to acute myeloid leukemia.